本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

IceCure Medical Ltd.

1.42
+0.04002.90%
盤後1.440.0200+1.41%19:47 EDT
成交量:17.21萬
成交額:24.23萬
市值:8,032.80萬
市盈率:-4.96
高:1.45
開:1.39
低:1.38
收:1.38
資料載入中...
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/11/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/10/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/03

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/11

SEC問詢函

Form CORRESP - Correspondence
2023/10/14

SEC問詢函

Form CORRESP - Correspondence
2023/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/22

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]